SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Q/C Technologies, Inc. (QCLS)

NASDAQ: QCLS · Real-Time Price · USD
0.63-0.06 (-8.42%)
 
Market Cap5.18M-85.9%
Revenue (ttm)n/a
Net Income-18.34M
EPS2.62
Shares Out8.19M
PE Ratio0.24
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume287,982
Open0.68
Previous Close0.69
Day's Range0.62 - 0.69
52-Week Range0.42 - 8.17
Beta2.33
Analystsnone
Price Targetn/a
Earnings Daten/a
-8.71% (1D)
No price history available.
Insider Score
––Not scored
QCLS Insider Score

Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About QCLS

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.

Address
1185 Avenue of the Americas, New York, NY, 10036, United States
Market Cap
5 million
Employees
3
Industrial Classification
Computer Hardware
1 Day
-8.41%
5 Days
-25.73%
1 Month
-67.25%
6 Months
-82.49%
1 Year
-85.86%

$QCLS stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in QCLS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by QCLS's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

QCLS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New QCLS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to QCLS from public contracts

Source: USAspending.gov

QCLS Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for QCLS yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from QCLS’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.